| Institution: | 1. Division of Evidence Based Medicine (dEBM), Department of Dematology, Venerology and Allergology, Charité – Universit?tsmedizin Berlin, Berlin, Germany;2. Department of Dermatology, Venerology and Allergology, Skin Cancer Center (HTCC), Charité – Universit?tsmedizin Berlin, Berlin, Germany;3. Department of Dermatology, Mayo Clinic, Scottsdale, Arizona, USA;4. Centro Dermatologia Epidermis, Instituto CUF and Faculty of Medicine of University of Porto, Porto, Portugal;5. Skin and Cancer Foundation Victoria, Carlton, Victoria, Australia;6. St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia;7. The University of Melbourne, Melbourne, Victoria, Australia;8. Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada;9. Mediprobe Research Inc., London, Ontario, Canada;10. Department of Dermatology, Medical University of Graz, Graz, Austria;11. Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA;12. Dermatology Laser Center of Maui, Kihei, Hawaii, USA;13. Division of Dermatology and Virginia Clinical Research Inc, Eastern Virginia Medical School, Norfolk, Virginia, USA;14. Division of Dermatopathology, Department of Dermatology, Venerology and Allergology, Charité – Universit?tsmedizin Berlin, Berlin, Germany;15. Department of Dermatology, Whipps Cross University Hospital, London, UK;16. Department of Pathology, Wake Forest Baptist Medical Center, Winston‐Salem, North Carolina, USA;17. Department of Dermatology, Wake Forest Baptist Medical Center, Winston‐Salem, North Carolina, USA;18. Department of Dermatology, Northern Medical School, University of Sydney, Sydney, New South Wales, Australia;19. Dermatology, Surgery, and Otolaryngology, Oregon Health and Science University, Portland, Oregon, USA;20. Surgical and Cosmetic Dermatology and Clinical Operations, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon, USA;21. Faculty of Medicine, Hospital das Clínicas, Universidade de S?o Paulo, S?o Paulo, Brazil |
